<style face="normal" font="default" size="100%">1409 Autoimmune disease and immunosuppressive therapy in relapsed long-term breast cancer survivors treated with cyclin-dependent kinase inhibitors and human epidermal receptor-2 monoclonal antibodies</style>

Drupal-HighWire